Biotechnology
The Biotechnology industry has a total of 584 stocks, with a combined market cap of $1.23 trillion and total revenue of $109.73 billion.
Market Cap
1.23T
Revenue
109.73B
Profits
-40.93B
PE Ratio
n/a
Profit Margin
-37.30%
Dividend Yield
0.04%
584 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 120.56B | 0.51% | 177,775 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 66.33B | 0.13% | 266,108 | 14.92B |
| 3 | ARGX | argenx SE | 54.15B | 5.14% | 158,525 | 5.32B |
| 4 | RVMD | Revolution Medicines, Inc. | 40.87B | 5.03% | 751,151 | - |
| 5 | ONC | BeOne Medicines AG | 36.14B | 1.62% | 97,409 | 5.74B |
| 6 | ALNY | Alnylam Pharmaceuticals, Inc. | 35.48B | -0.47% | 200,344 | 4.29B |
| 7 | RPRX | Royalty Pharma plc | 34.14B | 0.95% | 345,624 | 2.44B |
| 8 | ROIV | Roivant Sciences Ltd. | 25.50B | 1.55% | 757,952 | 8.26M |
| 9 | INCY | Incyte Corporation | 23.37B | 1.04% | 134,630 | 5.36B |
| 10 | INSM | Insmed Incorporated | 23.28B | 0.71% | 308,265 | 819.56M |
| 11 | BNTX | BioNTech SE | 23.17B | -0.21% | 118,348 | 3.23B |
| 12 | MRNA | Moderna, Inc. | 23.09B | 0.22% | 961,433 | 2.23B |
| 13 | GMAB | Genmab A/S | 17.91B | 0.21% | 326,703 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 16.84B | 1.41% | 22,093 | 998.25M |
| 15 | BBIO | BridgeBio Pharma, Inc. | 16.23B | 0.18% | 167,407 | 579.96M |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 15.80B | 0.44% | 54,453 | 4.44B |
| 17 | EXEL | Exelixis, Inc. | 13.94B | 0.85% | 300,384 | 2.38B |
| 18 | AXSM | Axsome Therapeutics, Inc. | 12.56B | 1.82% | 88,552 | 708.24M |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.54B | 1.18% | 29,960 | 1.13B |
| 20 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.51B | 0.11% | 506,480 | 622.01M |
| 21 | SMMT | Summit Therapeutics Inc. | 11.80B | 3.12% | 729,764 | - |
| 22 | ABVX | ABIVAX Société Anonyme | 11.35B | -0.66% | 171,656 | 5.67M |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 11.35B | 0.57% | 157,030 | 3.24B |
| 24 | TECH | Bio-Techne Corporation | 11.23B | 0.38% | 1,092,216 | 1.21B |
| 25 | CYTK | Cytokinetics, Incorporated | 11.22B | 0.51% | 219,473 | 105.82M |
| 26 | CORT | Corcept Therapeutics Incorporated | 10.35B | 6.13% | 150,377 | 769.10M |
| 27 | APGE | Apogee Therapeutics, Inc. | 10.08B | 0.15% | 209,385 | - |
| 28 | KRYS | Krystal Biotech, Inc. | 9.85B | -0.82% | 69,339 | 417.30M |
| 29 | IONS | Ionis Pharmaceuticals, Inc. | 9.45B | 5.91% | 1,138,153 | 1.06B |
| 30 | HALO | Halozyme Therapeutics, Inc. | 9.39B | 1.71% | 169,913 | 1.51B |
| 31 | KYMR | Kymera Therapeutics, Inc. | 9.15B | 0.82% | 74,412 | 51.48M |
| 32 | PRAX | Praxis Precision Medicines, Inc. | 8.87B | 1.94% | 84,627 | 7.46M |
| 33 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.83B | -0.02% | 2,268,497 | 18.07M |
| 34 | PTGX | Protagonist Therapeutics, Inc. | 8.81B | 1.17% | 116,416 | 74.06M |
| 35 | SYRE | Spyre Therapeutics, Inc. | 8.80B | 0.92% | 98,862 | - |
| 36 | PCVX | Vaxcyte, Inc. | 8.14B | 0.64% | 97,217 | - |
| 37 | IMVT | Immunovant, Inc. | 8.00B | -0.15% | 176,022 | - |
| 38 | IBRX | ImmunityBio, Inc. | 7.89B | 0.27% | 1,209,649 | 140.98M |
| 39 | TGTX | TG Therapeutics, Inc. | 7.60B | 1.75% | 478,623 | 700.35M |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.99B | -1.89% | 79,375 | 217.17M |
| 41 | COGT | Cogent Biosciences, Inc. | 6.82B | 0.91% | 518,949 | - |
| 42 | MIRM | Mirum Pharmaceuticals, Inc. | 6.80B | -2.61% | 406,218 | 569.61M |
| 43 | ERAS | Erasca, Inc. | 6.77B | -0.05% | 1,366,686 | - |
| 44 | PTCT | PTC Therapeutics, Inc. | 6.56B | 0.91% | 173,077 | 827.11M |
| 45 | CGON | CG Oncology, Inc. | 6.35B | 3.95% | 379,234 | 5.07M |
| 46 | XENE | Xenon Pharmaceuticals Inc. | 6.35B | -0.74% | 102,332 | 7.50M |
| 47 | BLTE | Belite Bio, Inc | 6.16B | -0.41% | 49,528 | - |
| 48 | LGND | Ligand Pharmaceuticals Incorporated | 6.00B | -0.39% | 62,251 | 274.48M |
| 49 | DFTX | Definium Therapeutics, Inc. | 5.84B | 0.82% | 149,460 | - |
| 50 | SRRK | Scholar Rock Holding Corporation | 5.84B | 0.97% | 274,330 | - |
| 51 | DNTH | Dianthus Therapeutics, Inc. | 5.78B | 2.88% | 161,947 | 1.34M |
| 52 | ORKA | Oruka Therapeutics, Inc. | 5.67B | 1.64% | 204,625 | - |
| 53 | TVTX | Travere Therapeutics, Inc. | 5.18B | -1.00% | 169,776 | 536.20M |
| 54 | CRSP | CRISPR Therapeutics AG | 4.74B | 1.84% | 646,554 | 4.10M |
| 55 | MANE | Veradermics, Incorporated | 4.73B | 2.99% | 71,872 | - |
| 56 | LEGN | Legend Biotech Corporation | 4.57B | 0.34% | 264,888 | 1.14B |
| 57 | CAI | Caris Life Sciences, Inc. | 4.47B | 2.80% | 574,137 | 907.29M |
| 58 | CELC | Celcuity Inc. | 4.44B | 1.04% | 260,631 | - |
| 59 | ACAD | ACADIA Pharmaceuticals Inc. | 4.25B | -0.64% | 311,976 | 1.10B |
| 60 | VKTX | Viking Therapeutics, Inc. | 4.24B | -2.17% | 1,428,973 | - |
| 61 | RLAY | Relay Therapeutics, Inc. | 4.21B | 0.36% | 303,108 | 10.68M |
| 62 | EWTX | Edgewise Therapeutics, Inc. | 4.13B | 0.03% | 111,256 | - |
| 63 | TNGX | Tango Therapeutics, Inc. | 4.05B | -0.25% | 207,682 | 56.99M |
| 64 | DYN | Dyne Therapeutics, Inc. | 3.96B | 3.15% | 1,080,844 | - |
| 65 | PBLS | Parabilis Medicines, Inc. | 3.89B | -0.94% | 133,638 | - |
| 66 | RCUS | Arcus Biosciences, Inc. | 3.88B | 3.00% | 234,564 | 236.00M |
| 67 | DNLI | Denali Therapeutics Inc. | 3.71B | -1.14% | 287,907 | - |
| 68 | ELVN | Enliven Therapeutics, Inc. | 3.69B | -0.09% | 73,504 | - |
| 69 | GPCR | Structure Therapeutics Inc. | 3.63B | 1.19% | 210,783 | - |
| 70 | NAMS | NewAmsterdam Pharma Company N.V. | 3.63B | -2.18% | 146,976 | 22.57M |
| 71 | ALMS | Alumis Inc. | 3.61B | -1.67% | 181,939 | 8.40M |
| 72 | TLX | Telix Pharmaceuticals Limited | 3.61B | 1.94% | 38,727 | 803.79M |
| 73 | ARQT | Arcutis Biotherapeutics, Inc. | 3.47B | -0.47% | 199,758 | 415.62M |
| 74 | IDYA | IDEAYA Biosciences, Inc. | 3.35B | 0.56% | 174,857 | 225.27M |
| 75 | MBX | MBX Biosciences, Inc. | 2.94B | 5.83% | 80,230 | - |
| 76 | IRON | Disc Medicine, Inc. | 2.86B | 0.88% | 49,969 | - |
| 77 | CLDX | Celldex Therapeutics, Inc. | 2.76B | 1.12% | 118,620 | 865.00K |
| 78 | QURE | uniQure N.V. | 2.72B | -1.96% | 173,037 | 18.09M |
| 79 | RARE | Ultragenyx Pharmaceutical Inc. | 2.71B | 0.02% | 210,387 | 670.00M |
| 80 | ATAI | AtaiBeckley Inc. | 2.65B | -0.07% | 1,938,522 | 3.49M |
| 81 | BEAM | Beam Therapeutics Inc. | 2.61B | -1.71% | 962,889 | 164.01M |
| 82 | KOD | Kodiak Sciences Inc. | 2.60B | -0.69% | 64,276 | - |
| 83 | VERA | Vera Therapeutics, Inc. | 2.57B | -0.60% | 148,744 | - |
| 84 | IMNM | Immunome, Inc. | 2.55B | -1.57% | 169,956 | 4.02M |
| 85 | NRIX | Nurix Therapeutics, Inc. | 2.49B | 1.82% | 213,627 | 36.77M |
| 86 | TRVI | Trevi Therapeutics, Inc. | 2.49B | 0.86% | 176,081 | - |
| 87 | SLS | SELLAS Life Sciences Group, Inc. | 2.46B | 3.73% | 1,812,643 | - |
| 88 | TARS | Tarsus Pharmaceuticals, Inc. | 2.45B | -1.08% | 56,992 | 535.08M |
| 89 | PHVS | Pharvaris N.V. | 2.39B | -0.61% | 91,793 | - |
| 90 | MLYS | Mineralys Therapeutics, Inc. | 2.36B | -0.89% | 248,107 | - |
| 91 | IOVA | Iovance Biotherapeutics, Inc. | 2.32B | 0.39% | 4,070,826 | 285.61M |
| 92 | NKTR | Nektar Therapeutics | 2.32B | -1.08% | 74,488 | 55.63M |
| 93 | ZLAB | Zai Lab Limited | 2.29B | -0.78% | 93,869 | 453.28M |
| 94 | VCEL | Vericel Corporation | 2.28B | 0.18% | 61,378 | 292.09M |
| 95 | NUVB | Nuvation Bio Inc. | 2.27B | -0.61% | 1,136,203 | 143.05M |
| 96 | KLRA | Kailera Therapeutics, Inc. | 2.24B | -2.98% | 117,450 | - |
| 97 | BHVN | Biohaven Ltd. | 2.21B | -0.61% | 202,033 | - |
| 98 | COAG | Hemab Therapeutics Holdings, Inc. | 2.20B | -4.23% | 97,419 | - |
| 99 | AGIO | Agios Pharmaceuticals, Inc. | 2.17B | 1.00% | 106,766 | 66.05M |
| 100 | VRDN | Viridian Therapeutics, Inc. | 2.16B | 1.83% | 209,721 | 70.92M |
| 101 | MESO | Mesoblast Limited | 2.11B | -1.41% | 22,188 | 65.38M |
| 102 | SION | Sionna Therapeutics, Inc. | 2.08B | 2.42% | 134,263 | - |
| 103 | URGN | UroGen Pharma Ltd. | 2.05B | -0.05% | 58,713 | 140.49M |
| 104 | HRMY | Harmony Biosciences Holdings, Inc. | 2.04B | 1.08% | 80,280 | 899.11M |
| 105 | KARD | Kardigan, Inc. | 2.03B | -0.37% | 16,070 | - |
| 106 | PVLA | Palvella Therapeutics, Inc. | 2.03B | -0.32% | 21,872 | - |
| 107 | NBTX | Nanobiotix S.A. | 2.01B | -0.94% | 41,633 | 38.27M |
| 108 | GLUE | Monte Rosa Therapeutics, Inc. | 2.00B | -0.29% | 63,005 | 42.95M |
| 109 | RAPP | Rapport Therapeutics, Inc. | 1.97B | -0.29% | 19,020 | 20.00M |
| 110 | AUPH | Aurinia Pharmaceuticals Inc. | 1.95B | -0.98% | 124,641 | 298.30M |
| 111 | ZBIO | Zenas BioPharma, Inc. | 1.95B | -2.10% | 62,550 | 10.00M |
| 112 | GHRS | GH Research PLC | 1.94B | -0.84% | 22,560 | - |
| 113 | ADMA | ADMA Biologics, Inc. | 1.94B | -0.36% | 529,668 | 509.86M |
| 114 | LKFT | Lakefront Biotherapeutics NV | 1.93B | -2.61% | 51,815 | 1.20B |
| 115 | SNDX | Syndax Pharmaceuticals, Inc. | 1.93B | -1.36% | 163,854 | 217.17M |
| 116 | PGEN | Precigen, Inc. | 1.86B | -1.69% | 482,328 | 31.60M |
| 117 | FTRE | Fortrea Holdings Inc. | 1.86B | 6.33% | 521,655 | 2.71B |
| 118 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.86B | 1.41% | 488,902 | 204.73M |
| 119 | OCUL | Ocular Therapeutix, Inc. | 1.85B | -1.81% | 477,819 | 52.04M |
| 120 | BCAX | Bicara Therapeutics Inc. | 1.84B | 0.43% | 40,451 | - |
| 121 | DMRA | Damora Therapeutics, Inc. | 1.84B | -0.40% | 66,612 | - |
| 122 | TSHA | Taysha Gene Therapies, Inc. | 1.81B | 0.09% | 391,211 | 7.47M |
| 123 | TYRA | Tyra Biosciences, Inc. | 1.81B | -0.72% | 82,143 | - |
| 124 | STOK | Stoke Therapeutics, Inc. | 1.80B | -0.41% | 63,885 | 32.08M |
| 125 | IMCR | Immunocore Holdings plc | 1.80B | -0.65% | 167,552 | 412.81M |
| 126 | ABCL | AbCellera Biologics Inc. | 1.75B | -0.17% | 676,435 | 79.21M |
| 127 | GENB | Generate Biomedicines, Inc. | 1.75B | -2.01% | 51,613 | 30.30M |
| 128 | AAPG | Ascentage Pharma Group International | 1.75B | - | 361 | 82.08M |
| 129 | SRPT | Sarepta Therapeutics, Inc. | 1.68B | 0.82% | 431,011 | 2.18B |
| 130 | ZYME | Zymeworks Inc. | 1.67B | -0.30% | 63,054 | 81.26M |
| 131 | ANAB | AnaptysBio, Inc. | 1.65B | 5.95% | 212,111 | 232.39M |
| 132 | MPLT | MapLight Therapeutics, Inc. | 1.63B | 1.67% | 39,430 | - |
| 133 | VIR | Vir Biotechnology, Inc. | 1.59B | 0.96% | 227,642 | 65.50M |
| 134 | NTLA | Intellia Therapeutics, Inc. | 1.58B | 1.44% | 966,860 | 66.09M |
| 135 | INVA | Innoviva, Inc. | 1.57B | -0.93% | 71,380 | 420.69M |
| 136 | MAZE | Maze Therapeutics, Inc. | 1.57B | -0.70% | 41,072 | 20.00M |
| 137 | RXRX | Recursion Pharmaceuticals, Inc. | 1.56B | -1.17% | 2,966,145 | 66.41M |
| 138 | MLTX | MoonLake Immunotherapeutics | 1.56B | -0.29% | 200,238 | - |
| 139 | SEPN | Septerna, Inc. | 1.53B | -0.91% | 113,985 | 72.26M |
| 140 | XNCR | Xencor, Inc. | 1.48B | 2.51% | 118,569 | 97.36M |
| 141 | SVRA | Savara Inc. | 1.43B | -0.53% | 252,033 | - |
| 142 | AVBP | ArriVent BioPharma, Inc. | 1.42B | 0.43% | 79,187 | - |
| 143 | ABSI | Absci Corporation | 1.37B | -2.18% | 509,646 | 1.84M |
| 144 | FBRX | Forte Biosciences, Inc. | 1.34B | -2.98% | 108,518 | - |
| 145 | AKTS | Aktis Oncology, Inc. | 1.33B | -2.86% | 57,698 | 8.28M |
| 146 | NVAX | Novavax, Inc. | 1.29B | -1.14% | 711,841 | 596.34M |
| 147 | TRAX | First Tracks Biotherapeutics, Inc. | 1.28B | -3.75% | 77,950 | - |
| 148 | AVLN | Avalyn Pharma Inc. | 1.27B | -0.42% | 60,464 | - |
| 149 | INBX | Inhibrx Biosciences, Inc. | 1.26B | 0.27% | 37,084 | 1.30M |
| 150 | ARDX | Ardelyx, Inc. | 1.25B | -0.49% | 659,820 | 427.68M |
| 151 | IMTX | Immatics N.V. | 1.25B | -0.65% | 46,494 | 43.00M |
| 152 | DRTS | Alpha Tau Medical Ltd. | 1.20B | 2.61% | 166,592 | - |
| 153 | MNKD | MannKind Corporation | 1.17B | -1.30% | 1,141,434 | 360.78M |
| 154 | SPTX | Seaport Therapeutics, Inc. | 1.17B | 2.44% | 4,511 | - |
| 155 | JBIO | Jade Biosciences, Inc. | 1.16B | -1.71% | 75,676 | - |
| 156 | CRVS | Corvus Pharmaceuticals, Inc. | 1.15B | -1.93% | 226,752 | - |
| 157 | ORIC | ORIC Pharmaceuticals, Inc. | 1.15B | 3.63% | 412,885 | - |
| 158 | MGTX | MeiraGTx Holdings plc | 1.12B | -0.53% | 59,759 | 79.76M |
| 159 | CAPR | Capricor Therapeutics, Inc. | 1.10B | 0.77% | 261,269 | 11.13M |
| 160 | WVE | Wave Life Sciences Ltd. | 1.10B | -0.52% | 309,049 | 71.80M |
| 161 | CGEM | Cullinan Therapeutics, Inc. | 1.07B | -1.02% | 79,787 | - |
| 162 | VOR | Vor Biopharma Inc. | 1.06B | -0.05% | 98,895 | - |
| 163 | IVA | Inventiva S.A. | 1.04B | -1.32% | 133,659 | 7.94M |
| 164 | EYPT | EyePoint, Inc. | 1.04B | -1.90% | 256,110 | 7.61M |
| 165 | ANRO | Alto Neuroscience, Inc. | 1.04B | -1.73% | 46,107 | - |
| 166 | LBRX | LB Pharmaceuticals Inc | 1.03B | -0.11% | 134,858 | - |
| 167 | OLMA | Olema Pharmaceuticals, Inc. | 1.02B | 1.31% | 154,632 | - |
| 168 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.00B | 0.22% | 527,626 | 69.64M |
| 169 | JANX | Janux Therapeutics, Inc. | 958.67M | 0.64% | 107,581 | 13.73M |
| 170 | AVTX | Avalo Therapeutics, Inc. | 958.60M | -0.17% | 85,182 | 59.00K |
| 171 | SANA | Sana Biotechnology, Inc. | 932.69M | -0.32% | 367,301 | - |
| 172 | KURA | Kura Oncology, Inc. | 930.36M | -0.57% | 209,746 | 71.64M |
| 173 | GERN | Geron Corporation | 920.58M | 1.77% | 1,104,304 | 196.12M |
| 174 | PHAR | Pharming Group N.V. | 920.50M | -2.62% | 451 | 369.49M |
| 175 | REPL | Replimune Group, Inc. | 918.36M | 1.77% | 284,810 | - |
| 176 | PHAT | Phathom Pharmaceuticals, Inc. | 917.42M | -1.28% | 101,197 | 204.89M |
| 177 | ODTX | Odyssey Therapeutics, Inc. | 880.00M | -1.24% | 27,027 | 1.06M |
| 178 | TBPH | Theravance Biopharma, Inc. | 873.82M | 0.30% | 74,324 | 109.78M |
| 179 | ABUS | Arbutus Biopharma Corporation | 866.20M | 1.27% | 400,329 | 191.45M |
| 180 | ANNX | Annexon, Inc. | 845.43M | -1.34% | 367,609 | - |
| 181 | DBVT | DBV Technologies S.A. | 828.78M | -0.88% | 30,212 | 5.04M |
| 182 | SLDB | Solid Biosciences Inc. | 783.66M | -1.73% | 191,500 | - |
| 183 | AURA | Aura Biosciences, Inc. | 774.30M | 0.14% | 27,074 | - |
| 184 | ACRS | Aclaris Therapeutics, Inc. | 768.85M | -2.05% | 153,200 | 8.37M |
| 185 | DRUG | Bright Minds Biosciences Inc. | 740.12M | -3.27% | 77,053 | - |
| 186 | TENX | Tenax Therapeutics, Inc. | 735.72M | -2.64% | 338,483 | - |
| 187 | FTH | Faeth Therapeutics, Inc. | 734.69M | -0.56% | 28,473 | - |
| 188 | CADL | Candel Therapeutics, Inc. | 732.70M | -0.89% | 173,820 | - |
| 189 | DSGN | Design Therapeutics, Inc. | 729.50M | -0.85% | 37,188 | - |
| 190 | CTMX | CytomX Therapeutics, Inc. | 728.22M | 0.45% | 316,048 | 35.54M |
| 191 | OMER | Omeros Corporation | 720.86M | 1.22% | 206,447 | 9.89M |
| 192 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 714.56M | 0.22% | 106,668 | - |
| 193 | ZVRA | Zevra Therapeutics, Inc. | 712.34M | -0.74% | 229,772 | 122.29M |
| 194 | CLYM | Climb Bio, Inc. | 710.03M | -1.43% | 93,506 | - |
| 195 | NGNE | Neurogene Inc. | 710.00M | -1.33% | 13,433 | 925.00K |
| 196 | OCS | Oculis Holding AG | 689.63M | -0.09% | 107,254 | 1.40M |
| 197 | MNPR | Monopar Therapeutics Inc. | 689.37M | -8.51% | 55,280 | - |
| 198 | CBIO | Crescent Biopharma, Inc. | 686.39M | 4.93% | 30,247 | 11.88M |
| 199 | SGP | SpyGlass Pharma, Inc. | 681.89M | -0.70% | 13,757 | - |
| 200 | RIGL | Rigel Pharmaceuticals, Inc. | 680.69M | -2.67% | 120,453 | 299.77M |
| 201 | GYRE | Gyre Therapeutics, Inc. | 660.01M | -0.34% | 5,532 | 117.05M |
| 202 | IMMX | Immix Biopharma, Inc. | 657.08M | -1.91% | 181,216 | - |
| 203 | ACHV | Achieve Life Sciences, Inc. | 644.70M | -0.48% | 270,312 | - |
| 204 | RGNX | REGENXBIO Inc. | 621.35M | -1.27% | 414,268 | 87.82M |
| 205 | CRMD | CorMedix Inc. | 621.34M | -0.25% | 106,097 | 400.05M |
| 206 | ALLO | Allogene Therapeutics, Inc. | 619.55M | -3.49% | 970,568 | 22.00K |
| 207 | MDXG | MiMedx Group, Inc. | 616.64M | -0.72% | 179,610 | 389.42M |
| 208 | NVCT | Nuvectis Pharma, Inc. | 615.69M | 1.24% | 72,901 | - |
| 209 | AGMB | AgomAb Therapeutics NV | 595.90M | 4.31% | 48,280 | - |
| 210 | TECX | Tectonic Therapeutic, Inc. | 591.55M | -0.76% | 13,282 | - |
| 211 | SPRY | ARS Pharmaceuticals, Inc. | 580.92M | -3.47% | 797,336 | 98.99M |
| 212 | FDMT | 4D Molecular Therapeutics, Inc. | 556.22M | -2.92% | 116,440 | 88.24M |
| 213 | SLN | Silence Therapeutics plc | 545.55M | -2.37% | 139,175 | 839.00K |
| 214 | PRME | Prime Medicine, Inc. | 545.46M | -2.27% | 539,463 | 4.03M |
| 215 | ALT | Altimmune, Inc. | 543.56M | -0.53% | 414,867 | 36.00K |
| 216 | VSTM | Verastem, Inc. | 543.06M | 4.92% | 366,942 | 49.59M |
| 217 | CTNM | Contineum Therapeutics, Inc. | 538.92M | -2.14% | 30,943 | - |
| 218 | ARVN | Arvinas, Inc. | 535.53M | 0.48% | 94,726 | 89.40M |
| 219 | RZLT | Rezolute, Inc. | 533.83M | 2.20% | 261,928 | - |
| 220 | ANL | Adlai Nortye Ltd. | 532.00M | 0.30% | 41,384 | 5.00M |
| 221 | STTK | Shattuck Labs, Inc. | 522.19M | -2.99% | 107,234 | 1.00M |
| 222 | RLMD | Relmada Therapeutics, Inc. | 519.21M | -1.00% | 466,173 | - |
| 223 | DNA | Ginkgo Bioworks Holdings, Inc. | 515.41M | 0.77% | 198,145 | 151.40M |
| 224 | EIKN | Eikon Therapeutics, Inc. | 510.53M | -1.87% | 24,056 | - |
| 225 | ZURA | Zura Bio Limited | 509.19M | -0.74% | 66,891 | - |
| 226 | ASMB | Assembly Biosciences, Inc. | 499.49M | -3.21% | 24,989 | 71.10M |
| 227 | SLBT | SL Science Holding Limited | 494.57M | -8.52% | 90,854 | 3.36M |
| 228 | HELP | Cybin Inc. | 489.05M | 0.90% | 274,852 | - |
| 229 | ARTV | Artiva Biotherapeutics, Inc. | 473.73M | -2.69% | 52,138 | 251.00K |
| 230 | VALN | Valneva SE | 463.62M | -0.10% | 3,675 | 180.25M |
| 231 | PROK | ProKidney Corp. | 453.09M | -1.96% | 285,508 | 889.00K |
| 232 | KYTX | Kyverna Therapeutics, Inc. | 448.06M | -0.41% | 208,691 | - |
| 233 | CABA | Cabaletta Bio, Inc. | 445.95M | -0.55% | 492,262 | - |
| 234 | PRTA | Prothena Corporation plc | 443.96M | 0.47% | 120,353 | 57.94M |
| 235 | OVID | Ovid Therapeutics Inc. | 441.40M | -0.63% | 3,724,704 | 7.12M |
| 236 | SGMT | Sagimet Biosciences Inc. | 430.41M | -1.13% | 200,122 | - |
| 237 | OCGN | Ocugen, Inc. | 426.54M | -2.33% | 1,173,178 | 4.47M |
| 238 | EPRX | Eupraxia Pharmaceuticals Inc. | 422.07M | -2.18% | 26,019 | - |
| 239 | EDIT | Editas Medicine, Inc. | 420.49M | -1.44% | 336,778 | 38.69M |
| 240 | LRMR | Larimar Therapeutics, Inc. | 419.10M | -0.12% | 167,014 | - |
| 241 | CCCC | C4 Therapeutics, Inc. | 409.10M | -1.07% | 307,652 | 34.86M |
| 242 | PBYI | Puma Biotechnology, Inc. | 399.56M | -0.25% | 60,123 | 227.18M |
| 243 | EVMN | Evommune, Inc. | 396.20M | -3.51% | 78,540 | 10.00M |
| 244 | VTVT | vTv Therapeutics Inc. | 390.78M | -0.57% | 73,478 | 36.84M |
| 245 | AUTL | Autolus Therapeutics plc | 385.91M | 0.69% | 172,481 | 92.62M |
| 246 | BNTC | Benitec Biopharma Inc. | 385.46M | -1.92% | 14,665 | - |
| 247 | IKT | Inhibikase Therapeutics, Inc. | 385.15M | 4.15% | 444,874 | 1.00 |
| 248 | IPSC | Century Therapeutics, Inc. | 384.16M | -0.93% | 94,840 | 109.16M |
| 249 | PRLD | Prelude Therapeutics Incorporated | 379.85M | -2.42% | 49,151 | 16.72M |
| 250 | STRO | Sutro Biopharma, Inc. | 379.46M | -2.14% | 31,965 | 99.61M |
| 251 | LXEO | Lexeo Therapeutics, Inc. | 378.47M | -1.03% | 145,874 | - |
| 252 | PALI | Palisade Bio, Inc. | 378.40M | 14.74% | 2,673,563 | - |
| 253 | AVIR | Atea Pharmaceuticals, Inc. | 376.93M | -2.08% | 42,540 | - |
| 254 | CMPX | Compass Therapeutics, Inc. | 372.78M | 1.47% | 261,796 | 850.00K |
| 255 | ENTA | Enanta Pharmaceuticals, Inc. | 365.52M | -3.75% | 18,855 | 69.21M |
| 256 | DMAC | DiaMedica Therapeutics Inc. | 365.33M | -2.24% | 39,852 | - |
| 257 | ABEO | Abeona Therapeutics Inc. | 364.20M | -0.47% | 262,328 | 14.54M |
| 258 | FENC | Fennec Pharmaceuticals Inc. | 354.67M | -1.07% | 29,244 | 51.00M |
| 259 | XFOR | X4 Pharmaceuticals, Inc. | 352.76M | 1.22% | 84,719 | 9.01M |
| 260 | UPB | Upstream Bio, Inc. | 345.57M | -3.64% | 122,304 | 3.32M |
| 261 | RCKT | Rocket Pharmaceuticals, Inc. | 345.05M | -4.24% | 497,106 | - |
| 262 | ZNTL | Zentalis Pharmaceuticals, Inc. | 330.30M | 3.11% | 240,828 | 26.87M |
| 263 | VCRE | Vicore Pharma Holding AB (publ) | 330.04M | -2.84% | 2,117 | 370.61K |
| 264 | VNDA | Vanda Pharmaceuticals Inc. | 321.12M | -0.19% | 162,136 | 217.78M |
| 265 | LYEL | Lyell Immunopharma, Inc. | 318.56M | 1.25% | 19,911 | 31.00K |
| 266 | INDP | Indaptus Therapeutics, Inc. | 315.38M | 5.29% | 27,758 | - |
| 267 | FHTX | Foghorn Therapeutics Inc. | 299.44M | -2.11% | 17,865 | 28.22M |
| 268 | OABI | OmniAb, Inc. | 297.92M | -2.61% | 48,547 | 28.94M |
| 269 | FATE | Fate Therapeutics, Inc. | 296.06M | -1.55% | 607,224 | 6.32M |
| 270 | BCYC | Bicycle Therapeutics plc | 290.41M | -1.19% | 24,543 | 63.50M |
| 271 | TTRX | Turn Therapeutics Inc. | 288.05M | 0.52% | 9,339 | - |
| 272 | ELDN | Eledon Pharmaceuticals, Inc. | 286.41M | -0.40% | 225,637 | - |
| 273 | SLGL | Sol-Gel Technologies Ltd. | 284.73M | 3.32% | 6,764 | 18.47M |
| 274 | NMRA | Neumora Therapeutics, Inc. | 279.78M | -1.95% | 88,361 | - |
| 275 | IMRX | Immuneering Corporation | 279.49M | -3.36% | 189,195 | - |
| 276 | LCTX | Lineage Cell Therapeutics, Inc. | 271.74M | -1.80% | 467,294 | 14.78M |
| 277 | SABS | SAB Biotherapeutics, Inc. | 268.77M | -1.82% | 89,082 | 114.70K |
| 278 | MGNX | MacroGenics, Inc. | 265.69M | -2.79% | 126,789 | 157.08M |
| 279 | IFRX | InflaRx N.V. | 263.65M | -0.56% | 150,047 | 33.82K |
| 280 | ALXO | ALX Oncology Holdings Inc. | 262.40M | -3.47% | 98,223 | - |
| 281 | AGEN | Agenus Inc. | 261.35M | 5.61% | 587,901 | 123.87M |
| 282 | QTTB | Q32 Bio Inc. | 258.08M | 0.93% | 168,575 | 53.74M |
| 283 | NAGE | Niagen Bioscience, Inc. | 256.19M | -5.45% | 222,144 | 130.42M |
| 284 | PRQR | ProQR Therapeutics N.V. | 254.02M | -0.55% | 216,849 | 15.73M |
| 285 | SRZN | Surrozen, Inc. | 250.32M | -0.74% | 12,484 | 7.49M |
| 286 | CNXU | Conexeu Sciences Inc. | 245.51M | -1.77% | 18,838 | - |
| 287 | IRD | Opus Genetics, Inc. | 245.22M | -2.62% | 324,875 | 11.98M |
| 288 | FULC | Fulcrum Therapeutics, Inc. | 243.54M | -1.22% | 280,683 | 80.00M |
| 289 | OTLK | Outlook Therapeutics, Inc. | 243.10M | -2.99% | 2,738,840 | 333.14K |
| 290 | ADAG | Adagene Inc. | 233.57M | -1.26% | 1,018 | 7.67M |
| 291 | AVXL | Anavex Life Sciences Corp. | 233.53M | -1.18% | 136,426 | - |
| 292 | RNAC | Cartesian Therapeutics, Inc. | 230.20M | -3.63% | 20,505 | 1.78M |
| 293 | NAUT | Nautilus Biotechnology, Inc. | 226.20M | 4.71% | 88,351 | - |
| 294 | TARA | Protara Therapeutics, Inc. | 225.66M | -1.59% | 74,626 | - |
| 295 | GALT | Galectin Therapeutics Inc. | 223.91M | -2.86% | 119,476 | - |
| 296 | CGEN | Compugen Ltd. | 223.22M | -2.48% | 82,128 | 72.66M |
| 297 | ACIU | AC Immune SA | 219.23M | -2.64% | 31,101 | 4.62M |
| 298 | CHRS | Coherus Oncology, Inc. | 218.26M | -1.05% | 155,486 | 46.88M |
| 299 | TRDA | Entrada Therapeutics, Inc. | 216.20M | -2.44% | 108,022 | 5.74M |
| 300 | OBIO | Orchestra BioMed Holdings, Inc. | 214.37M | -1.38% | 44,634 | 32.72M |
| 301 | WHWK | Whitehawk Therapeutics, Inc. | 207.33M | -3.38% | 170,085 | 7.15M |
| 302 | CLLS | Cellectis S.A. | 207.15M | - | 227 | 75.11M |
| 303 | RNA | Atrium Therapeutics, Inc. | 205.10M | -1.48% | 20,588 | 36.68M |
| 304 | NBP | NovaBridge Biosciences | 202.96M | 0.86% | 243,026 | - |
| 305 | IMUX | Immunic, Inc. | 202.28M | -1.72% | 10,358 | - |
| 306 | NERV | Minerva Neurosciences, Inc. | 201.03M | -2.60% | 20,908 | - |
| 307 | KROS | Keros Therapeutics, Inc. | 199.50M | -1.27% | 46,353 | 33.18M |
| 308 | MENS | Jyong Biotech Ltd. | 195.98M | - | 27,611 | - |
| 309 | ARMP | Armata Pharmaceuticals, Inc. | 193.83M | 0.76% | 29,441 | 5.20M |
| 310 | IVVD | Invivyd, Inc. | 190.58M | 4.32% | 995,884 | 55.87M |
| 311 | GLSI | Greenwich LifeSciences, Inc. | 189.35M | -2.79% | 72,389 | - |
| 312 | PLX | Protalix BioTherapeutics, Inc. | 187.73M | -1.69% | 122,268 | 76.38M |
| 313 | DTIL | Precision BioSciences, Inc. | 186.03M | -1.50% | 44,508 | 45.07M |
| 314 | CDXS | Codexis, Inc. | 183.61M | -1.94% | 87,204 | 78.09M |
| 315 | MDWD | MediWound Ltd. | 183.14M | -1.18% | 14,824 | 14.48M |
| 316 | VYGR | Voyager Therapeutics, Inc. | 180.66M | -3.55% | 192,394 | 36.49M |
| 317 | NGEN | NervGen Pharma Corp. | 178.42M | -2.33% | 77,933 | - |
| 318 | HUMA | Humacyte, Inc. | 175.51M | 0.98% | 595,177 | 2.02M |
| 319 | NRXP | NRx Pharmaceuticals, Inc. | 174.77M | -6.92% | 254,330 | 2.29M |
| 320 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 174.72M | 6.67% | 298,273 | - |
| 321 | EQ | Equillium, Inc. | 174.51M | - | 72,245 | 4.39M |
| 322 | ANTX | AN2 Therapeutics, Inc. | 173.60M | -1.43% | 12,469 | - |
| 323 | TNYA | Tenaya Therapeutics, Inc. | 172.19M | 0.57% | 394,018 | 225.00K |
| 324 | OKUR | OnKure Therapeutics, Inc. | 171.96M | -1.46% | 11,755 | - |
| 325 | ACOG | Alpha Cognition Inc. | 170.71M | -0.76% | 40,985 | 10.83M |
| 326 | ALEC | Alector, Inc. | 170.42M | 0.33% | 331,748 | 18.42M |
| 327 | TNXP | Tonix Pharmaceuticals Holding Corp. | 167.70M | -0.66% | 95,959 | 17.56M |
| 328 | IPHA | Innate Pharma S.A. | 167.27M | -0.28% | 1,383 | 10.57M |
| 329 | PYXS | Pyxis Oncology, Inc. | 167.26M | 4.35% | 453,340 | 13.86M |
| 330 | ARCT | Arcturus Therapeutics Holdings Inc. | 166.84M | -1.01% | 88,252 | 54.71M |
| 331 | NKTX | Nkarta, Inc. | 165.63M | -3.94% | 296,758 | - |
| 332 | LENZ | LENZ Therapeutics, Inc. | 165.55M | -1.12% | 162,785 | 20.99M |
| 333 | ORMP | Oramed Pharmaceuticals Inc. | 164.11M | -0.25% | 39,262 | 2.00M |
| 334 | KZIA | Kazia Therapeutics Limited | 163.63M | -1.92% | 15,515 | 1.27M |
| 335 | MIST | Milestone Pharmaceuticals Inc. | 161.22M | -0.42% | 282,796 | 1.78M |
| 336 | KRRO | Korro Bio, Inc. | 160.23M | -5.04% | 30,766 | 3.84M |
| 337 | CRBU | Caribou Biosciences, Inc. | 160.18M | -2.71% | 167,047 | 11.20M |
| 338 | CNTN | Canton Strategic Holdings, Inc. | 158.49M | -1.67% | 127,061 | - |
| 339 | KPTI | Karyopharm Therapeutics Inc. | 157.05M | -3.48% | 152,310 | 151.12M |
| 340 | ABOS | Acumen Pharmaceuticals, Inc. | 155.29M | -2.71% | 78,323 | - |
| 341 | CAMP | Camp4 Therapeutics Corporation | 154.22M | -4.50% | 33,396 | 3.93M |
| 342 | YDES | YD Bio Limited | 152.50M | -1.87% | 3,455 | 510.36K |
| 343 | UNCY | Unicycive Therapeutics, Inc. | 150.66M | -1.26% | 237,345 | - |
| 344 | MOLN | Molecular Partners AG | 149.87M | - | 20 | 856.30K |
| 345 | AARD | Aardvark Therapeutics, Inc. | 144.00M | 1.86% | 45,767 | - |
| 346 | CNTB | Connect Biopharma Holdings Limited | 139.48M | 0.70% | 45,922 | 233.00K |
| 347 | CUE | Cue Biopharma, Inc. | 138.33M | -3.71% | 30,621 | 32.73M |
| 348 | HURA | TuHURA Biosciences, Inc. | 137.55M | -3.57% | 82,989 | - |
| 349 | PEPG | PepGen Inc. | 134.19M | 1.04% | 296,888 | - |
| 350 | CBUS | Cibus, Inc. | 133.58M | -2.23% | 18,420 | 4.29M |
| 351 | GNLX | Genelux Corporation | 132.34M | 0.68% | 58,437 | 8.00K |
| 352 | PMN | ProMIS Neurosciences, Inc. | 122.32M | -2.50% | 5,303 | - |
| 353 | GUTS | Fractyl Health, Inc. | 122.24M | 1.65% | 670,205 | 3.00K |
| 354 | ENGN | enGene Therapeutics Inc. | 121.59M | -1.89% | 255,316 | - |
| 355 | SPRB | Spruce Biosciences, Inc. | 121.09M | -1.36% | 10,009 | 697.00K |
| 356 | ANIX | Anixa Biosciences, Inc. | 120.10M | 0.28% | 85,638 | - |
| 357 | FBIO | Fortress Biotech, Inc. | 118.09M | 0.14% | 97,950 | 66.16M |
| 358 | TLSA | Tiziana Life Sciences Ltd | 117.67M | -3.70% | 132,544 | - |
| 359 | VANI | Vivani Medical, Inc. | 117.58M | -1.90% | 49,093 | - |
| 360 | SEER | Seer, Inc. | 111.61M | -1.93% | 96,900 | 15.17M |
| 361 | BDTX | Black Diamond Therapeutics, Inc. | 105.44M | 0.55% | 76,411 | 70.00M |
| 362 | PLYX | Polaryx Therapeutics, Inc. | 104.16M | -1.79% | 13,726 | - |
| 363 | RANI | Rani Therapeutics Holdings, Inc. | 103.58M | -6.76% | 619,750 | 3.17M |
| 364 | ENTX | Entera Bio Ltd. | 101.54M | 1.48% | 37,972 | 42.00K |
| 365 | COYA | Coya Therapeutics, Inc. | 100.15M | -2.30% | 36,487 | 7.94M |
| 366 | ALDX | Aldeyra Therapeutics, Inc. | 99.53M | -2.94% | 355,267 | - |
| 367 | ICCC | ImmuCell Corporation | 99.51M | -1.17% | 762 | 29.93M |
| 368 | ONCY | Oncolytics Biotech Inc. | 97.87M | -0.92% | 231,283 | - |
| 369 | KLRS | Kalaris Therapeutics, Inc. | 96.83M | - | 22,351 | - |
| 370 | NTHI | NeOnc Technologies Holdings, Inc. | 96.30M | 1.18% | 3,081 | 39.99K |
| 371 | VRCA | Verrica Pharmaceuticals Inc. | 94.66M | -3.33% | 4,497 | 37.16M |
| 372 | PTHS | Pelthos Therapeutics Inc. | 90.09M | -2.08% | 4,167 | 27.70M |
| 373 | BMEA | Biomea Fusion, Inc. | 89.65M | -3.88% | 61,511 | - |
| 374 | RLYB | Rallybio Corporation | 88.32M | 0.30% | 5,634 | 858.00K |
| 375 | ATHE | Alterity Therapeutics Limited | 87.51M | 4.68% | 3,233 | 4.43M |
| 376 | ACET | Adicet Bio, Inc. | 86.63M | -3.73% | 71,747 | - |
| 377 | NRXS | NeurAxis, Inc. | 86.38M | 1.53% | 2,647 | 4.28M |
| 378 | HRTX | Heron Therapeutics, Inc. | 86.10M | -2.72% | 156,859 | 150.71M |
| 379 | INO | Inovio Pharmaceuticals, Inc. | 85.15M | -2.36% | 563,944 | 65.34K |
| 380 | CGTX | Cognition Therapeutics, Inc. | 83.23M | -3.34% | 80,025 | - |
| 381 | ALPS | Alps Group Inc | 82.12M | 3.68% | 1,629 | 3.74M |
| 382 | PYPD | PolyPid Ltd. | 79.57M | 3.75% | 95,683 | - |
| 383 | CSBR | Champions Oncology, Inc. | 79.29M | -6.85% | 211 | 57.95M |
| 384 | MAIA | MAIA Biotechnology, Inc. | 78.74M | -0.38% | 111,133 | - |
| 385 | OKYO | OKYO Pharma Limited | 78.19M | -1.97% | 88,250 | - |
| 386 | TELO | Telomir Pharmaceuticals, Inc. | 77.76M | 6.66% | 14,802 | - |
| 387 | GANX | Gain Therapeutics, Inc. | 77.63M | -1.09% | 42,782 | - |
| 388 | PMVP | PMV Pharmaceuticals, Inc. | 73.06M | 3.01% | 97,284 | - |
| 389 | ANVS | Annovis Bio, Inc. | 72.75M | -1.72% | 78,652 | - |
| 390 | RNTX | Rein Therapeutics Inc. | 72.57M | -7.14% | 409,952 | - |
| 391 | ATRA | Atara Biotherapeutics, Inc. | 71.55M | -2.27% | 9,302 | 23.14M |
| 392 | ENLV | Enlivex Ltd. | 71.51M | -2.94% | 11,702 | - |
| 393 | ACRV | Acrivon Therapeutics, Inc. | 71.48M | -0.60% | 93,311 | - |
| 394 | LONA | LeonaBio, Inc. | 71.39M | 0.53% | 1,086 | - |
| 395 | SPRO | Spero Therapeutics, Inc. | 71.10M | -3.31% | 312,338 | 61.19M |
| 396 | XBIT | XBiotech Inc. | 69.51M | 0.44% | 16,411 | - |
| 397 | OSTX | OS Therapies Incorporated | 68.14M | -1.29% | 61,146 | - |
| 398 | IBIO | iBio, Inc. | 68.06M | -0.72% | 77,750 | 300.00K |
| 399 | PLRX | Pliant Therapeutics, Inc. | 66.87M | -1.82% | 196,437 | - |
| 400 | GOSS | Gossamer Bio, Inc. | 66.48M | -5.95% | 5,035,015 | 55.54M |
| 401 | CING | Cingulate Inc. | 64.79M | -0.62% | 20,054 | - |
| 402 | MNOV | MediciNova, Inc. | 63.99M | -2.26% | 22,728 | 596.64K |
| 403 | IMA | ImageneBio, Inc. | 62.37M | -7.37% | 1,303 | 800.00K |
| 404 | ELTX | Elicio Therapeutics, Inc. | 59.50M | - | 51,730 | - |
| 405 | TCRX | TScan Therapeutics, Inc. | 58.36M | -0.73% | 262,135 | 9.14M |
| 406 | HYFT | MindWalk Holdings Corp. | 58.11M | -18.75% | 439,554 | 11.43M |
| 407 | CRDF | Cardiff Oncology, Inc. | 57.55M | -2.12% | 92,129 | 525.00K |
| 408 | BOLD | Boundless Bio, Inc. | 56.61M | - | 60,883 | - |
| 409 | CNTX | Context Therapeutics Inc. | 56.57M | 0.37% | 198,489 | - |
| 410 | XLO | Xilio Therapeutics, Inc. | 53.19M | 4.83% | 9,354 | 53.48M |
| 411 | IMMP | Immutep Limited | 51.56M | 0.28% | 84,358 | 5.28M |
| 412 | INKT | MiNK Therapeutics, Inc. | 51.01M | - | 377 | - |
| 413 | MCRB | Seres Therapeutics, Inc. | 50.94M | -0.38% | 10,910 | 1.15M |
| 414 | DYAI | Dyadic International, Inc. | 49.86M | 5.25% | 127,878 | 3.81M |
| 415 | EDSA | Edesa Biotech, Inc. | 49.79M | -1.41% | 17,359 | - |
| 416 | VRXA | Veraxa Biotech AG | 49.17M | -4.88% | 109,735 | - |
| 417 | ELOX | Eloxx Pharmaceuticals, Inc. | 48.94M | -2.77% | 4,521 | - |
| 418 | MREO | Mereo BioPharma Group plc | 48.89M | 2.92% | 226,903 | 500.00K |
| 419 | DWTX | Dogwood Therapeutics, Inc. | 48.76M | -0.68% | 2,150 | - |
| 420 | IBO | Impact BioMedical Inc. | 48.63M | 4.81% | 6,079 | 39.00K |
| 421 | TIL | Instil Bio, Inc. | 48.56M | -1.24% | 2,279 | - |
| 422 | RADX | Radiopharm Theranostics Limited | 47.20M | - | - | 10.86M |
| 423 | ATYR | aTyr Pharma, Inc. | 46.23M | -3.18% | 276,295 | 190.00K |
| 424 | INMB | INmune Bio Inc. | 46.03M | -5.91% | 151,389 | 50.00K |
| 425 | MGX | Metagenomi Therapeutics, Inc. | 45.93M | -1.61% | 12,896 | 22.33M |
| 426 | BYSI | BeyondSpring Inc. | 44.82M | -3.54% | 6,977 | 1.88M |
| 427 | FLNA | Filana Therapeutics, Inc. | 43.72M | -6.14% | 135,589 | - |
| 428 | EXOZ | eXoZymes, Inc. | 43.39M | -0.25% | 1,516 | -700.00 |
| 429 | HYPD | Hyperion DeFi, Inc. | 41.68M | -0.36% | 84,901 | 1.04M |
| 430 | APLM | Apollomics, Inc. | 41.51M | 1.61% | 6,481 | 8.84M |
| 431 | GNTA | Genenta Science S.p.A. | 39.16M | 1.22% | 86,017 | - |
| 432 | PDSB | PDS Biotechnology Corporation | 39.15M | -1.97% | 103,402 | - |
| 433 | RNXT | RenovoRx, Inc. | 38.90M | -0.34% | 10,567 | 1.49M |
| 434 | GRCE | Grace Therapeutics, Inc. | 38.57M | - | 33,381 | - |
| 435 | NTRB | Nutriband Inc. | 36.95M | -0.33% | 2,856 | 1.80M |
| 436 | NNVC | NanoViricides, Inc. | 36.45M | 5.26% | 98,517 | - |
| 437 | VERU | Veru Inc. | 36.43M | 0.44% | 51,922 | 16.89M |
| 438 | CRVO | CervoMed Inc. | 36.39M | -3.24% | 115,480 | 2.09M |
| 439 | LTRN | Lantern Pharma Inc. | 35.72M | -1.41% | 19,864 | - |
| 440 | LITS | Lite Strategy, Inc. | 34.71M | -0.97% | 61,450 | - |
| 441 | ESLA | Estrella Immunopharma, Inc. | 33.14M | 1.18% | 1,403 | - |
| 442 | SER | Serina Therapeutics, Inc. | 32.84M | 0.92% | 18,404 | 130.00K |
| 443 | BCTX | BriaCell Therapeutics Corp. | 31.87M | -0.42% | 3,421 | - |
| 444 | ALGS | Aligos Therapeutics, Inc. | 30.63M | -3.88% | 33,553 | 4.71M |
| 445 | ACTU | Actuate Therapeutics, Inc. | 30.14M | -0.40% | 20,293 | - |
| 446 | VYNE | VYNE Therapeutics Inc. | 29.58M | -1.18% | 352,366 | 454.00K |
| 447 | KYNB | Kyntra Bio, Inc. | 29.19M | -0.07% | 866 | 7.44M |
| 448 | ABVC | ABVC BioPharma, Inc. | 29.19M | -2.12% | 20,221 | 797.92K |
| 449 | ATNM | Actinium Pharmaceuticals, Inc. | 27.78M | -1.61% | 53,320 | 90.00K |
| 450 | PLRZ | Polyrizon Ltd. | 26.67M | -0.97% | 16,257 | - |
| 451 | PSTV | Plus Therapeutics, Inc. | 26.57M | 1.05% | 9,046 | 5.18M |
| 452 | IGC | IGC Pharma, Inc. | 26.34M | -2.48% | 79,686 | 1.11M |
| 453 | EVAX | Evaxion A/S | 25.77M | 1.64% | 282 | 7.53M |
| 454 | BRNS | Barinthus Biotherapeutics plc | 25.57M | 4.32% | 5,278 | 14.97M |
| 455 | TVRD | Tvardi Therapeutics, Inc. | 24.39M | -5.80% | 225,224 | - |
| 456 | CELU | Celularity Inc. | 23.74M | 5.13% | 1,333 | 26.55M |
| 457 | NRSN | NeuroSense Therapeutics Ltd. | 23.65M | 2.92% | 30,283 | - |
| 458 | SKYE | Skye Bioscience, Inc. | 23.55M | 4.65% | 17,873 | - |
| 459 | GRDX | GridAI Technologies Corp. | 21.96M | -3.51% | 1,611 | - |
| 460 | NEUP | Neuphoria Therapeutics Inc. | 21.62M | 20.12% | 6,591,719 | -13.27K |
| 461 | ATOS | Atossa Therapeutics, Inc. | 21.44M | 2.47% | 6,940 | - |
| 462 | MRKR | Marker Therapeutics, Inc. | 21.34M | 3.23% | 4,574 | 3.55M |
| 463 | CVM | CEL-SCI Corporation | 20.97M | -2.44% | 19,463 | - |
| 464 | JSPR | Jasper Therapeutics, Inc. | 20.64M | -1.01% | 205,062 | - |
| 465 | NCEL | NewcelX Ltd. | 20.43M | 3.97% | 5,844 | - |
| 466 | CLRB | Cellectar Biosciences, Inc. | 20.06M | 1.62% | 14,230 | - |
| 467 | ALLR | Allarity Therapeutics, Inc. | 20.05M | -1.57% | 15,281 | 345.00K |
| 468 | LSTA | Lisata Therapeutics, Inc. | 19.85M | -0.91% | 24,090 | 170.00K |
| 469 | LGVN | Longeveron Inc. | 19.59M | -1.04% | 51,362 | 1.22M |
| 470 | PLUR | Pluri Inc. | 18.88M | -5.41% | 10,999 | 1.08M |
| 471 | TVGN | Tevogen Bio Holdings Inc. | 18.31M | 2.36% | 2,114 | - |
| 472 | QNCX | Quince Therapeutics, Inc. | 18.22M | 0.51% | 5,291 | - |
| 473 | QNTM | Quantum BioPharma Ltd. | 18.17M | -0.35% | 28,270 | - |
| 474 | DARE | Daré Bioscience, Inc. | 18.13M | -0.82% | 72,654 | 1.16M |
| 475 | LPCN | Lipocine Inc. | 17.97M | -2.24% | 4,095 | 2.00M |
| 476 | HOWL | Werewolf Therapeutics, Inc. | 17.51M | -1.37% | 12,267 | 1.14M |
| 477 | AKTX | Akari Therapeutics, Plc | 17.18M | 0.05% | 9,942 | - |
| 478 | PTN | Palatin Technologies, Inc. | 17.10M | -0.61% | 1,313 | 12.88M |
| 479 | MLEC | Moolec Science SA | 16.62M | 7.97% | 2,985 | 7.83M |
| 480 | KTTA | Pasithea Therapeutics Corp. | 16.21M | 5.43% | 172,334 | - |
| 481 | NXTC | NextCure, Inc. | 15.89M | - | 83,801 | - |
| 482 | PASG | Passage Bio, Inc. | 15.78M | - | 78 | - |
| 483 | CYCN | Cyclerion Therapeutics, Inc. | 15.48M | 0.55% | 462 | 1.99M |
| 484 | ICU | SeaStar Medical Holding Corporation | 15.36M | -1.80% | 26,826 | 1.44M |
| 485 | OSRH | OSR Health, Inc. | 15.11M | -1.94% | 95,584 | 2.63M |
| 486 | CTXR | Citius Pharmaceuticals, Inc. | 14.84M | -3.89% | 74,244 | 5.61M |
| 487 | HIND | Vyome Holdings, Inc. | 14.75M | -0.89% | 2,634 | 152.72K |
| 488 | TPST | Tempest Therapeutics, Inc. | 14.47M | 2.78% | 326,106 | - |
| 489 | SNTI | Senti Biosciences Holdings, Inc. | 14.01M | 2.13% | 16,918 | 38.00K |
| 490 | LEXX | Lexaria Bioscience Corp. | 14.00M | 1.00% | 11,881 | 194.00K |
| 491 | COCP | Cocrystal Pharma, Inc. | 13.37M | 3.58% | 11,326 | 225.00K |
| 492 | BLRX | BioLineRx Ltd. | 12.86M | 4.23% | 2,836 | 1.40M |
| 493 | PHIO | Phio Pharmaceuticals Corp. | 12.78M | 3.77% | 29,148 | - |
| 494 | KALA | KALA BIO, Inc. | 12.14M | -11.31% | 111,861 | - |
| 495 | GTBP | GT Biopharma, Inc. | 12.09M | -3.01% | 116,636 | - |
| 496 | LNAI | Lunai Bioworks Inc. | 11.97M | 1.15% | 10,657 | 20.94K |
| 497 | INTS | Intensity Therapeutics, Inc. | 11.95M | 0.68% | 1,669 | - |
| 498 | INAB | IN8bio, Inc. | 11.82M | -2.44% | 3,306 | - |
| 499 | CALC | CalciMedica, Inc. | 11.57M | -1.58% | 28,687 | - |
| 500 | KPRX | Kiora Pharmaceuticals, Inc. | 11.21M | - | 67 | 20.00K |